These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2197091)
61. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children. Wible K; Tregnaghi M; Bruss J; Fleishaker D; Naberhuis-Stehouwer S; Hilty M Pediatr Infect Dis J; 2003 Apr; 22(4):315-23. PubMed ID: 12690270 [TBL] [Abstract][Full Text] [Related]
62. Clinical comparison of cefadroxil, new oral cephalosporin, and cephalexin in uncomplicated urinary tract infection. Bolding OT Urology; 1978 Sep; 12(3):321-4. PubMed ID: 360561 [TBL] [Abstract][Full Text] [Related]
63. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract. Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055 [TBL] [Abstract][Full Text] [Related]
64. One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam. Jernelius H; Zbornik J; Bauer CA Acta Med Scand; 1988; 223(5):469-77. PubMed ID: 3287839 [TBL] [Abstract][Full Text] [Related]
65. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI). Wagenlehner FM; Umeh O; Steenbergen J; Yuan G; Darouiche RO Lancet; 2015 May; 385(9981):1949-56. PubMed ID: 25931244 [TBL] [Abstract][Full Text] [Related]
66. Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole. Seidmon EJ; Krisch EB; Truant AL; Amy BG; Childs SJ; Hurst AT; McCabe RE Urology; 1990 Feb; 35(2):187-93. PubMed ID: 2407023 [TBL] [Abstract][Full Text] [Related]
67. Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections. Corrado ML; Hesney M; Struble WE; Brown KR; Eng RH; Landes R; Harrison L; Ryan J; Bolding OT Eur Urol; 1990; 17 Suppl 1():34-9. PubMed ID: 2191867 [TBL] [Abstract][Full Text] [Related]
68. Norfloxacin: a three-day course for the treatment of urinary tract infection. Ganguli LA; Keaney MG; Gould LJ Drugs Exp Clin Res; 1985; 11(3):177-9. PubMed ID: 3836125 [TBL] [Abstract][Full Text] [Related]
69. Urinary tract infections with low and high colony counts in young women. Spontaneous remission and single-dose vs multiple-day treatment. Arav-Boger R; Leibovici L; Danon YL Arch Intern Med; 1994 Feb; 154(3):300-4. PubMed ID: 8297196 [TBL] [Abstract][Full Text] [Related]
70. Therapy of symptomatic pyelonephritis in women. Gleckman R; Bradley P; Roth R; Hibert D; Pelletier C J Urol; 1985 Feb; 133(2):176-8. PubMed ID: 3881598 [TBL] [Abstract][Full Text] [Related]
71. A comparison of erythromycin and cefadroxil in the prevention of flare-ups from asymptomatic teeth with pulpal necrosis and associated periapical pathosis. Morse DR; Furst ML; Lefkowitz RD; D'Angelo D; Esposito JV Oral Surg Oral Med Oral Pathol; 1990 May; 69(5):619-30. PubMed ID: 2185452 [TBL] [Abstract][Full Text] [Related]
72. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis. Randolph MF Chemotherapy; 1988; 34(6):512-8. PubMed ID: 3243093 [TBL] [Abstract][Full Text] [Related]
73. Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections. Rugendorff EW Drugs; 1987; 34 Suppl 1():91-4. PubMed ID: 3481333 [TBL] [Abstract][Full Text] [Related]
75. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections. Karachalios GN; Georgiopoulos AN Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736 [TBL] [Abstract][Full Text] [Related]
76. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Richard GA; Klimberg IN; Fowler CL; Callery-D'Amico S; Kim SS Urology; 1998 Jul; 52(1):51-5. PubMed ID: 9671870 [TBL] [Abstract][Full Text] [Related]
77. Erythromycin versus cefadroxil in the treatment of skin infections. Heskel NS; Siepman NC; Pichotta PJ; Green EM; Stoll RW Int J Dermatol; 1992 Feb; 31(2):131-3. PubMed ID: 1559738 [TBL] [Abstract][Full Text] [Related]
78. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Goel G; King T; Daveson AJ; Andrews JM; Krishnarajah J; Krause R; Brown GJE; Fogel R; Barish CF; Epstein R; Kinney TP; Miner PB; Tye-Din JA; Girardin A; Taavela J; Popp A; Sidney J; Mäki M; Goldstein KE; Griffin PH; Wang S; Dzuris JL; Williams LJ; Sette A; Xavier RJ; Sollid LM; Jabri B; Anderson RP Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):479-493. PubMed ID: 28506538 [TBL] [Abstract][Full Text] [Related]
79. [Double-blind comparison of cefadroxil and cephalexin granules in the treatment of impetigo]. Arata J; Nohara N; Suwaki M; Umemura S; Nakagawa S; Miyoshi K; Yamamoto Y; Nishihara O; Yamada M; Hiramatsu H Jpn J Antibiot; 1983 Jun; 36(6):1443-60. PubMed ID: 6361311 [TBL] [Abstract][Full Text] [Related]
80. Cefadroxil in the management of facial cellulitis of odontogenic origin. Hanna CB Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):496-8. PubMed ID: 2052337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]